Rohto Pharmaceutical Co.,Ltd. (TYO:4527)
1,984.00
-3.00 (-0.15%)
Jun 6, 2025, 3:30 PM JST
Rohto Pharmaceutical Revenue
In the fiscal year ending March 31, 2025, Rohto Pharmaceutical had annual revenue of 308.63B JPY with 13.95% growth. Rohto Pharmaceutical had revenue of 82.73B in the quarter ending March 31, 2025, with 18.73% growth.
Revenue
308.63B
Revenue Growth
+13.95%
P/S Ratio
1.45
Revenue / Employee
42.52M
Employees
7,259
Market Cap
448.31B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 308.63B | 37.79B | 13.95% |
Mar 31, 2024 | 270.84B | 32.18B | 13.48% |
Mar 31, 2023 | 238.66B | 39.02B | 19.54% |
Mar 31, 2022 | 199.65B | 18.36B | 10.13% |
Mar 31, 2021 | 181.29B | -7.04B | -3.74% |
Mar 31, 2020 | Pro | Pro | Pro |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Japan Tobacco | 3,236.41B |
Seven & i Holdings | 11.97T |
Ajinomoto Co. | 1,530.56B |
Kao Corporation | 1,652.51B |
Asahi Group Holdings | 2,953.23B |
Pan Pacific International Holdings | 2,215.91B |
Unicharm | 980.22B |
Kirin Holdings Company | 2,382.48B |